JP2012502051A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502051A5 JP2012502051A5 JP2011526217A JP2011526217A JP2012502051A5 JP 2012502051 A5 JP2012502051 A5 JP 2012502051A5 JP 2011526217 A JP2011526217 A JP 2011526217A JP 2011526217 A JP2011526217 A JP 2011526217A JP 2012502051 A5 JP2012502051 A5 JP 2012502051A5
- Authority
- JP
- Japan
- Prior art keywords
- sulfonyl
- trifluoromethyl
- pyrazole
- alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 139
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 89
- 229910052736 halogen Inorganic materials 0.000 claims 75
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 73
- 150000002367 halogens Chemical class 0.000 claims 66
- -1 C 1 -C 6 alkoxy Chemical group 0.000 claims 62
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 46
- 150000003839 salts Chemical class 0.000 claims 39
- 150000001875 compounds Chemical class 0.000 claims 35
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 30
- 229910052799 carbon Inorganic materials 0.000 claims 30
- 125000001072 heteroaryl group Chemical group 0.000 claims 29
- 125000004076 pyridyl group Chemical group 0.000 claims 29
- 125000003118 aryl group Chemical group 0.000 claims 28
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 25
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 24
- 125000005843 halogen group Chemical group 0.000 claims 23
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 22
- 125000003226 pyrazolyl group Chemical group 0.000 claims 21
- 125000001188 haloalkyl group Chemical group 0.000 claims 19
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 16
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 16
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 16
- 125000002541 furyl group Chemical group 0.000 claims 16
- 125000004438 haloalkoxy group Chemical group 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 15
- 125000002883 imidazolyl group Chemical group 0.000 claims 15
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 14
- 125000000335 thiazolyl group Chemical group 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 11
- 125000002971 oxazolyl group Chemical group 0.000 claims 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims 10
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 10
- 125000003386 piperidinyl group Chemical group 0.000 claims 10
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 10
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 10
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 9
- UREWVVFRSGFOEL-UHFFFAOYSA-N cyclohepta[c]pyrazole Chemical compound C1=CC=CC=C2C=NN=C21 UREWVVFRSGFOEL-UHFFFAOYSA-N 0.000 claims 9
- 208000024827 Alzheimer disease Diseases 0.000 claims 8
- 125000001041 indolyl group Chemical group 0.000 claims 8
- 125000004193 piperazinyl group Chemical group 0.000 claims 8
- 125000000168 pyrrolyl group Chemical group 0.000 claims 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 125000005336 allyloxy group Chemical group 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 230000004770 neurodegeneration Effects 0.000 claims 6
- 208000015122 neurodegenerative disease Diseases 0.000 claims 6
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 5
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 5
- 125000004663 dialkyl amino group Chemical group 0.000 claims 5
- 229910052731 fluorine Inorganic materials 0.000 claims 5
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 5
- 125000004043 oxo group Chemical group O=* 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 4
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 4
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 4
- 125000005605 benzo group Chemical group 0.000 claims 4
- 208000010877 cognitive disease Diseases 0.000 claims 4
- 125000001786 isothiazolyl group Chemical group 0.000 claims 4
- 210000004558 lewy body Anatomy 0.000 claims 4
- 208000027061 mild cognitive impairment Diseases 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 4
- 125000001544 thienyl group Chemical group 0.000 claims 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 3
- VTQCNQGBQQMBLV-UHFFFAOYSA-N 10,13-difluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound N1N=CC2=C1CC1C=3C(F)=CC=C(F)C=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 VTQCNQGBQQMBLV-UHFFFAOYSA-N 0.000 claims 3
- WUQDUTFTTFEVBT-UHFFFAOYSA-N 10-fluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound N1N=CC2=C1CC1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 WUQDUTFTTFEVBT-UHFFFAOYSA-N 0.000 claims 3
- OIXUCUMJGNILSS-UHFFFAOYSA-N 11,12-difluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound C1=2C=C(F)C(F)=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 OIXUCUMJGNILSS-UHFFFAOYSA-N 0.000 claims 3
- AXRMLETUVFOEGG-UHFFFAOYSA-N 11-fluoro-13-methyl-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=2C(C)=CC(F)=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 AXRMLETUVFOEGG-UHFFFAOYSA-N 0.000 claims 3
- BHOIZHXQNAQNDM-UHFFFAOYSA-N 12-chloro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(Cl)C=C12 BHOIZHXQNAQNDM-UHFFFAOYSA-N 0.000 claims 3
- SFXDZFWHZSQBJK-UHFFFAOYSA-N 12-fluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C12=CC(F)=CC=C2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 SFXDZFWHZSQBJK-UHFFFAOYSA-N 0.000 claims 3
- XAGIJOHXUNDGDQ-UHFFFAOYSA-N 13-fluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=2C(F)=CC=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 XAGIJOHXUNDGDQ-UHFFFAOYSA-N 0.000 claims 3
- LPGNFEMHCAETQT-UHFFFAOYSA-N 13-fluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=2C(F)=CC=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 LPGNFEMHCAETQT-UHFFFAOYSA-N 0.000 claims 3
- LAOYPXQZBFCCPD-UHFFFAOYSA-N 14-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-10-thia-4,5,12,14-tetrazatetracyclo[6.5.1.02,6.09,13]tetradeca-2(6),3,9(13),11-tetraene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C2N=CS1 LAOYPXQZBFCCPD-UHFFFAOYSA-N 0.000 claims 3
- YTKPUCGEYIEMSQ-UHFFFAOYSA-N 15-(4-chlorophenyl)sulfonyl-13-fluoro-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaen-7-one Chemical compound C1=NNC(C2=O)=C1C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(Cl)C=C1 YTKPUCGEYIEMSQ-UHFFFAOYSA-N 0.000 claims 3
- AYFGISGEVPLQGS-UHFFFAOYSA-N 15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=CC=C12 AYFGISGEVPLQGS-UHFFFAOYSA-N 0.000 claims 3
- SONMNLUMLBERFJ-UHFFFAOYSA-N 15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=CC=C12 SONMNLUMLBERFJ-UHFFFAOYSA-N 0.000 claims 3
- XMZJFGJDGLSCRD-UHFFFAOYSA-N 19-[4-(trifluoromethyl)phenyl]sulfonyl-15,16,19-triazapentacyclo[10.6.1.02,11.03,8.013,17]nonadeca-2(11),3,5,7,9,13(17),14-heptaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C3C=CC=CC3=CC=C12 XMZJFGJDGLSCRD-UHFFFAOYSA-N 0.000 claims 3
- PZTOCUZOSPFKQZ-UHFFFAOYSA-N 7,7,13-trifluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NNC(C2(F)F)=C1C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 PZTOCUZOSPFKQZ-UHFFFAOYSA-N 0.000 claims 3
- ZVMAHZWUDYKAJT-UHFFFAOYSA-N 9-phenyl-12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C(C=1C=CC=CC=1)CC2 ZVMAHZWUDYKAJT-UHFFFAOYSA-N 0.000 claims 3
- VTVZNYAJEPPMGO-UHFFFAOYSA-N C12=CC(C(=O)OC)=CC=C2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 Chemical compound C12=CC(C(=O)OC)=CC=C2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 VTVZNYAJEPPMGO-UHFFFAOYSA-N 0.000 claims 3
- BGXCRHVOAPQTIS-UHFFFAOYSA-N C1=2C(F)=CC=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(Cl)C=C1 Chemical compound C1=2C(F)=CC=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(Cl)C=C1 BGXCRHVOAPQTIS-UHFFFAOYSA-N 0.000 claims 3
- DBBDPKUPNWYZPS-UHFFFAOYSA-N N1N=CC2=C1CC1C3=CC(F)=CN=C3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 Chemical compound N1N=CC2=C1CC1C3=CC(F)=CN=C3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 DBBDPKUPNWYZPS-UHFFFAOYSA-N 0.000 claims 3
- WVHPESSRIMHJJY-UHFFFAOYSA-N N1N=CC2=C1CC1C=3C(F)=CC=CC=3CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound N1N=CC2=C1CC1C=3C(F)=CC=CC=3CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 WVHPESSRIMHJJY-UHFFFAOYSA-N 0.000 claims 3
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 3
- 229910052794 bromium Inorganic materials 0.000 claims 3
- 150000001721 carbon Chemical group 0.000 claims 3
- HWZSDECUKARGIQ-UHFFFAOYSA-N chembl1837048 Chemical compound FC1=CC=CC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=NC(=CC=3)C(F)(F)F)C2)=C1 HWZSDECUKARGIQ-UHFFFAOYSA-N 0.000 claims 3
- SKKNGTJHVDVDQB-UHFFFAOYSA-N chembl571186 Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1C2CC(C#N)CC1CC1=C2C=NN1 SKKNGTJHVDVDQB-UHFFFAOYSA-N 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 125000000262 haloalkenyl group Chemical group 0.000 claims 3
- 125000000232 haloalkynyl group Chemical group 0.000 claims 3
- OMBNWRCJUMAOGY-UHFFFAOYSA-N methyl 15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene-10-carboxylate Chemical compound N1N=CC2=C1CC1C=3C(C(=O)OC)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 OMBNWRCJUMAOGY-UHFFFAOYSA-N 0.000 claims 3
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims 3
- 125000001425 triazolyl group Chemical group 0.000 claims 3
- CICHLBYBQZIZAR-OFLPRAFFSA-N (7S)-10-fluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaen-7-ol Chemical compound C1([C@@H](C=2NN=CC=2C2C=3C1=C(F)C=CC=3)O)N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 CICHLBYBQZIZAR-OFLPRAFFSA-N 0.000 claims 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims 2
- 125000006643 (C2-C6) haloalkenyl group Chemical group 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 2
- MYQQZBPXYQRKIU-UHFFFAOYSA-N 10-chloro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C(Cl)C=CC=C12 MYQQZBPXYQRKIU-UHFFFAOYSA-N 0.000 claims 2
- SYNQSTLMIXGNQH-UHFFFAOYSA-N 11,12-difluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound C1=2C=C(F)C(F)=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 SYNQSTLMIXGNQH-UHFFFAOYSA-N 0.000 claims 2
- KBHFFDXWOFSHAZ-UHFFFAOYSA-N 12-(4-fluorophenyl)-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(F)=CC=C1C1=CC=C(C2N(C3C=4C=NNC=4C2)S(=O)(=O)C=2C=NC(=CC=2)C(F)(F)F)C3=C1 KBHFFDXWOFSHAZ-UHFFFAOYSA-N 0.000 claims 2
- SHQVIXPYJLOUIP-UHFFFAOYSA-N 12-bromo-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,13,15-tetrazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(Br)N=C12 SHQVIXPYJLOUIP-UHFFFAOYSA-N 0.000 claims 2
- YQLKBYRERWEPIS-UHFFFAOYSA-N 12-cyclopropyl-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(C3CC3)C=C12 YQLKBYRERWEPIS-UHFFFAOYSA-N 0.000 claims 2
- PVXSHEWMWTYCAP-UHFFFAOYSA-N 13-chloro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C2C(Cl)=CC=C1 PVXSHEWMWTYCAP-UHFFFAOYSA-N 0.000 claims 2
- DFOQDRDKMQKNQI-UHFFFAOYSA-N 15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,10,15-tetrazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=NC=CC=C12 DFOQDRDKMQKNQI-UHFFFAOYSA-N 0.000 claims 2
- DJPISMZFHGHKBX-UHFFFAOYSA-N 15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,13,15-tetrazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=CN=C12 DJPISMZFHGHKBX-UHFFFAOYSA-N 0.000 claims 2
- BCDXATZVEVRGMG-UHFFFAOYSA-N 15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaen-7-one Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(=O)C(NN=C3)=C3C1C1=CC=CC=C12 BCDXATZVEVRGMG-UHFFFAOYSA-N 0.000 claims 2
- IOGYGVYXDUMWGA-UHFFFAOYSA-N 15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene-11-carbonitrile Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(C#N)=CC=C12 IOGYGVYXDUMWGA-UHFFFAOYSA-N 0.000 claims 2
- GYFGMJUPZUUYKY-UHFFFAOYSA-N 3-bromo-16-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-12,13,16-triazatetracyclo[7.6.1.02,7.010,14]hexadeca-2(7),3,5,10(14),11-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C3=C(Br)C=CC=C3CC1C(C=NN1)=C1C2 GYFGMJUPZUUYKY-UHFFFAOYSA-N 0.000 claims 2
- LOMAEMKJOHISQZ-UHFFFAOYSA-N 3-bromo-16-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-12,13,16-triazatetracyclo[7.6.1.02,7.011,15]hexadeca-2(7),3,5,11(15),13-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1CC1=CC=CC(Br)=C12 LOMAEMKJOHISQZ-UHFFFAOYSA-N 0.000 claims 2
- CJHWBGRYNSGINR-UHFFFAOYSA-N 3-methyl-5-[15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaen-12-yl]-1,2,4-oxadiazole Chemical compound CC1=NOC(C=2C=C3C4C=5C=NNC=5CC(N4S(=O)(=O)C=4C=NC(=CC=4)C(F)(F)F)C3=CC=2)=N1 CJHWBGRYNSGINR-UHFFFAOYSA-N 0.000 claims 2
- RXLJWRLNHRWBCH-UHFFFAOYSA-N 3-methyl-5-[15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaen-10-yl]-1,2,4-oxadiazole Chemical compound CC1=NOC(C=2C=3C4N(C(C=5C=NNC=5C4)C=3C=CC=2)S(=O)(=O)C=2C=NC(=CC=2)C(F)(F)F)=N1 RXLJWRLNHRWBCH-UHFFFAOYSA-N 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- LJIGOHMIOSPZKP-UHFFFAOYSA-N 8-methyl-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaen-7-one Chemical compound C=1C=CC=C2C=1C1C=3C=NNC=3C(=O)C2(C)N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 LJIGOHMIOSPZKP-UHFFFAOYSA-N 0.000 claims 2
- CXTALZQHRDKDJD-OFLPRAFFSA-N C1([C@@H](C=2NN=CC=2C2C=3C(=CC=CC1=3)F)O)N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 Chemical compound C1([C@@H](C=2NN=CC=2C2C=3C(=CC=CC1=3)F)O)N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 CXTALZQHRDKDJD-OFLPRAFFSA-N 0.000 claims 2
- SJBBSCRLCUDUBL-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C2C2=CC=CC=C2C=C1 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C2C2=CC=CC=C2C=C1 SJBBSCRLCUDUBL-UHFFFAOYSA-N 0.000 claims 2
- RJNYDZQFLJAULE-UHFFFAOYSA-N C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(Cl)=CC=C12 Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(Cl)=CC=C12 RJNYDZQFLJAULE-UHFFFAOYSA-N 0.000 claims 2
- XIQFPYYLCMDWKS-UHFFFAOYSA-N C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(Br)C=C12 Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(Br)C=C12 XIQFPYYLCMDWKS-UHFFFAOYSA-N 0.000 claims 2
- HAZZTMGXPIMONG-UHFFFAOYSA-N C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(C3CC3)N=C12 Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(C3CC3)N=C12 HAZZTMGXPIMONG-UHFFFAOYSA-N 0.000 claims 2
- CWCIPSOPTBXNIK-UHFFFAOYSA-N C=1C=CC=C2C=1C1C=3C=NNC=3C(=O)C2(C)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound C=1C=CC=C2C=1C1C=3C=NNC=3C(=O)C2(C)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 CWCIPSOPTBXNIK-UHFFFAOYSA-N 0.000 claims 2
- SJMWMJWPMICQDP-UHFFFAOYSA-N CN1N=CC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(Cl)=CC=3)C2)=N1 Chemical compound CN1N=CC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(Cl)=CC=3)C2)=N1 SJMWMJWPMICQDP-UHFFFAOYSA-N 0.000 claims 2
- 208000005145 Cerebral amyloid angiopathy Diseases 0.000 claims 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- 201000010374 Down Syndrome Diseases 0.000 claims 2
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 208000016988 Hemorrhagic Stroke Diseases 0.000 claims 2
- 208000032382 Ischaemic stroke Diseases 0.000 claims 2
- MMKFJQJMWSBFPD-UHFFFAOYSA-N N1=NN(C)C=C1C1CC(N2S(=O)(=O)C=3C=CC(Cl)=CC=3)C(C=NN3)=C3CC2C1 Chemical compound N1=NN(C)C=C1C1CC(N2S(=O)(=O)C=3C=CC(Cl)=CC=3)C(C=NN3)=C3CC2C1 MMKFJQJMWSBFPD-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 201000007737 Retinal degeneration Diseases 0.000 claims 2
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 2
- 206010044688 Trisomy 21 Diseases 0.000 claims 2
- 206010064930 age-related macular degeneration Diseases 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 206010002022 amyloidosis Diseases 0.000 claims 2
- 210000004556 brain Anatomy 0.000 claims 2
- 208000029028 brain injury Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000005052 dihydropyrazolyl group Chemical group N1(NCC=C1)* 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000002489 hematologic effect Effects 0.000 claims 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000002632 imidazolidinyl group Chemical group 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 208000020658 intracerebral hemorrhage Diseases 0.000 claims 2
- 230000000302 ischemic effect Effects 0.000 claims 2
- 208000002780 macular degeneration Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 230000004258 retinal degeneration Effects 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- 230000009529 traumatic brain injury Effects 0.000 claims 2
- GKBCARCQHHRETI-USXIJHARSA-N (1R,7R,8R)-7,13-difluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound N1([C@H]2[C@H](C=3NN=CC=3[C@@H]1C=1C(=CC=CC2=1)F)F)S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 GKBCARCQHHRETI-USXIJHARSA-N 0.000 claims 1
- GKBCARCQHHRETI-XIRDDKMYSA-N (1S,7R,8S)-7,13-difluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound N1([C@@H]2[C@H](C=3NN=CC=3[C@H]1C=1C(=CC=CC2=1)F)F)S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 GKBCARCQHHRETI-XIRDDKMYSA-N 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- MIGHYBXBFPKGML-UHFFFAOYSA-N 1-[4-[12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-dien-10-yl]phenyl]pyrrolidin-2-one Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3C(CCC3)=O)CC1CC1=C2C=NN1 MIGHYBXBFPKGML-UHFFFAOYSA-N 0.000 claims 1
- GPYVSQOCAZCYSL-UHFFFAOYSA-N 10-(1,3-benzodioxol-5-yl)-12-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=C4OCOC4=CC=3)CC1CC1=C2C=NN1 GPYVSQOCAZCYSL-UHFFFAOYSA-N 0.000 claims 1
- NAZGUWUTHXJYAY-UHFFFAOYSA-N 10-(2H-tetrazol-5-yl)-12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C3=NNN=N3)CC1CC1=C2C=NN1 NAZGUWUTHXJYAY-UHFFFAOYSA-N 0.000 claims 1
- IIECBPYKHRNKON-UHFFFAOYSA-N 10-(3-imidazol-1-ylphenyl)-12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=C(C=CC=3)N3C=NC=C3)CC1CC1=C2C=NN1 IIECBPYKHRNKON-UHFFFAOYSA-N 0.000 claims 1
- VJBBVEGSZUEWTQ-UHFFFAOYSA-N 10-(3-pyrazol-1-ylphenyl)-12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=C(C=CC=3)N3N=CC=C3)CC1CC1=C2C=NN1 VJBBVEGSZUEWTQ-UHFFFAOYSA-N 0.000 claims 1
- JWGPBXFDPYYAGP-UHFFFAOYSA-N 10-(4-methoxyphenyl)-12-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(OC)=CC=C1C1CC(N2S(=O)(=O)C=3C=NC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 JWGPBXFDPYYAGP-UHFFFAOYSA-N 0.000 claims 1
- UVGIVEQBHQKKKR-UHFFFAOYSA-N 10-(4-pyrazol-1-ylphenyl)-12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3N=CC=C3)CC1CC1=C2C=NN1 UVGIVEQBHQKKKR-UHFFFAOYSA-N 0.000 claims 1
- ZBLHKDWGAISPNU-UHFFFAOYSA-N 10-(fluoromethyl)-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound N1N=CC2=C1CC1C=3C(CF)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 ZBLHKDWGAISPNU-UHFFFAOYSA-N 0.000 claims 1
- LGZYIAUXBNPCCU-UHFFFAOYSA-N 10-[4-(1,2,4-triazol-1-yl)phenyl]-12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3N=CN=C3)CC1CC1=C2C=NN1 LGZYIAUXBNPCCU-UHFFFAOYSA-N 0.000 claims 1
- FLJYQRYVAFAIIW-UHFFFAOYSA-N 10-chloro-7-methylidene-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(=C)C(NN=C3)=C3C1C1=C2C(Cl)=CC=C1 FLJYQRYVAFAIIW-UHFFFAOYSA-N 0.000 claims 1
- DBVJQUGBJZIXEP-UHFFFAOYSA-N 10-cyclopropyl-11-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,11-triazatricyclo[6.2.1.02,6]undeca-2(6),3,9-triene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C=C2C1CC1 DBVJQUGBJZIXEP-UHFFFAOYSA-N 0.000 claims 1
- BSSUXTFLZBGTPP-UHFFFAOYSA-N 10-cyclopropyl-11-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,11-triazatricyclo[6.2.1.02,6]undeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C3CC3)CC1CC1=C2C=NN1 BSSUXTFLZBGTPP-UHFFFAOYSA-N 0.000 claims 1
- WYULLIXWUXXBQM-UHFFFAOYSA-N 10-cyclopropyl-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C(C3CC3)C=CC=C12 WYULLIXWUXXBQM-UHFFFAOYSA-N 0.000 claims 1
- CNCJSUYUWWZATQ-UHFFFAOYSA-N 10-fluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaen-7-one Chemical compound N1N=CC2=C1C(=O)C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 CNCJSUYUWWZATQ-UHFFFAOYSA-N 0.000 claims 1
- UKVHTRHEAPQBHW-UHFFFAOYSA-N 11,12-difluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaen-7-one Chemical compound N1N=CC2=C1C(=O)C1C=3C=C(F)C(F)=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 UKVHTRHEAPQBHW-UHFFFAOYSA-N 0.000 claims 1
- YCLTZMRZEZEAOV-UHFFFAOYSA-N 11,12-difluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaen-7-one Chemical compound N1N=CC2=C1C(=O)C1C=3C=C(F)C(F)=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 YCLTZMRZEZEAOV-UHFFFAOYSA-N 0.000 claims 1
- DOIJKTFHIPRLGB-UHFFFAOYSA-N 11-(trifluoromethyl)-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(C(F)(F)F)=CC=C12 DOIJKTFHIPRLGB-UHFFFAOYSA-N 0.000 claims 1
- COGPSDSDJBWMRQ-UHFFFAOYSA-N 11-phenyl-12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=3C=CC=CC=3)CCC1CC1=C2C=NN1 COGPSDSDJBWMRQ-UHFFFAOYSA-N 0.000 claims 1
- PMTLKPIKBCUVHC-UHFFFAOYSA-N 12-(4-chlorophenyl)sulfonyl-10-(1-methoxycyclopropyl)-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1C(N2S(=O)(=O)C=3C=CC(Cl)=CC=3)CC=3NN=CC=3C2CC1C1(OC)CC1 PMTLKPIKBCUVHC-UHFFFAOYSA-N 0.000 claims 1
- PLCGDCIKHKGJJI-UHFFFAOYSA-N 12-(4-chlorophenyl)sulfonyl-10-pyridin-4-yl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-diene Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1C2CC(C=3C=CN=CC=3)CC1CC1=C2C=NN1 PLCGDCIKHKGJJI-UHFFFAOYSA-N 0.000 claims 1
- BTLVPUVNHHHOBL-UHFFFAOYSA-N 12-(4-fluorophenyl)-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,13,15-tetrazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(F)=CC=C1C1=CC=C(C2N(C3C=4C=NNC=4C2)S(=O)(=O)C=2C=NC(=CC=2)C(F)(F)F)C3=N1 BTLVPUVNHHHOBL-UHFFFAOYSA-N 0.000 claims 1
- OIMVVVBSSKSYTP-UHFFFAOYSA-N 12-(trifluoromethyl)-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=C(C(F)(F)F)C=C12 OIMVVVBSSKSYTP-UHFFFAOYSA-N 0.000 claims 1
- DHWLDDVVABIYPA-UHFFFAOYSA-N 13-cyclopropyl-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C2C(C2CC2)=CC=C1 DHWLDDVVABIYPA-UHFFFAOYSA-N 0.000 claims 1
- FCSHZLBGHKQDGC-UHFFFAOYSA-N 13-fluoro-15-(4-fluorophenyl)sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=C2C(F)=CC=C1 FCSHZLBGHKQDGC-UHFFFAOYSA-N 0.000 claims 1
- FHTDRRPPSIIVKT-UHFFFAOYSA-N 13-fluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaen-7-one Chemical compound C1=NNC(C2=O)=C1C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 FHTDRRPPSIIVKT-UHFFFAOYSA-N 0.000 claims 1
- NSXTXFTZKVIORX-UHFFFAOYSA-N 13-fluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaen-7-one Chemical compound C1=NNC(C2=O)=C1C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 NSXTXFTZKVIORX-UHFFFAOYSA-N 0.000 claims 1
- APNOWSZCEWCWBX-UHFFFAOYSA-N 15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,11,15-tetrazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CN=CC=C12 APNOWSZCEWCWBX-UHFFFAOYSA-N 0.000 claims 1
- DDFINCUBPYNRGQ-UHFFFAOYSA-N 15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaen-7-one Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(=O)C(NN=C3)=C3C1C1=CC=CC=C12 DDFINCUBPYNRGQ-UHFFFAOYSA-N 0.000 claims 1
- LNNBVNKEPCPJFS-UHFFFAOYSA-N 2-N-[4-[12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-dien-10-yl]phenyl]cyclohexane-1,2-diamine Chemical compound NC1CCCCC1NC1=CC=C(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C2)C=C1 LNNBVNKEPCPJFS-UHFFFAOYSA-N 0.000 claims 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 claims 1
- CDZCREIHDRCTHZ-UHFFFAOYSA-N 2h-cyclohepta[c]pyridine Chemical compound C1=CC=CC2=CNC=CC2=C1 CDZCREIHDRCTHZ-UHFFFAOYSA-N 0.000 claims 1
- RYIWNFGDJVFMGD-UHFFFAOYSA-N 4-[4-[12-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-dien-10-yl]phenyl]-1,3-thiazole Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)C=3N=CSC=3)CC1CC1=C2C=NN1 RYIWNFGDJVFMGD-UHFFFAOYSA-N 0.000 claims 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- FRCKYHZZVAZMBD-UHFFFAOYSA-N 5-[12-(4-chlorophenyl)sulfonyl-4,5,12-triazatricyclo[6.3.1.02,6]dodeca-2(6),3-dien-10-yl]-3-methyl-1,2-oxazole Chemical compound O1N=C(C)C=C1C1CC(N2S(=O)(=O)C=3C=CC(Cl)=CC=3)C(C=NN3)=C3CC2C1 FRCKYHZZVAZMBD-UHFFFAOYSA-N 0.000 claims 1
- HPQLAOLLIHMOCA-UHFFFAOYSA-N 6-(4-fluorophenyl)-16-[4-(trifluoromethyl)phenyl]sulfonyl-12,13,16-triazatetracyclo[7.6.1.02,7.011,15]hexadeca-2,4,6,11(15),13-pentaene Chemical compound C1=CC(F)=CC=C1C1=CC=CC2=C1CC1N(S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C2C(C=NN2)=C2C1 HPQLAOLLIHMOCA-UHFFFAOYSA-N 0.000 claims 1
- YKAHJBZWTLSLDX-UHFFFAOYSA-N 6-[3-(trifluoromethyl)phenyl]-16-[4-(trifluoromethyl)phenyl]sulfonyl-12,13,16-triazatetracyclo[7.6.1.02,7.010,14]hexadeca-2,4,6,10(14),11-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=CC=C3C=4C=C(C=CC=4)C(F)(F)F)=C3CC1C(C=NN1)=C1C2 YKAHJBZWTLSLDX-UHFFFAOYSA-N 0.000 claims 1
- XXWFKZUTBAKMQQ-UHFFFAOYSA-N 6-[3-(trifluoromethyl)phenyl]-16-[4-(trifluoromethyl)phenyl]sulfonyl-12,13,16-triazatetracyclo[7.6.1.02,7.011,15]hexadeca-2,4,6,11(15),13-pentaene Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1CC1=C(C=3C=C(C=CC=3)C(F)(F)F)C=CC=C12 XXWFKZUTBAKMQQ-UHFFFAOYSA-N 0.000 claims 1
- IQWCJKNANUABPL-UHFFFAOYSA-N 6-cyclopropyl-16-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-12,13,16-triazatetracyclo[7.6.1.02,7.011,15]hexadeca-2,4,6,11(15),13-pentaene Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1CC1=C(C3CC3)C=CC=C12 IQWCJKNANUABPL-UHFFFAOYSA-N 0.000 claims 1
- APOOAIAIGJFPGE-UHFFFAOYSA-N 7,7,10-trifluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound N1N=CC2=C1C(F)(F)C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 APOOAIAIGJFPGE-UHFFFAOYSA-N 0.000 claims 1
- NGZZTQBKXULJKK-UHFFFAOYSA-N 7,7,10-trifluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound N1N=CC2=C1C(F)(F)C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 NGZZTQBKXULJKK-UHFFFAOYSA-N 0.000 claims 1
- ZIQJRGUIJUOBCN-UHFFFAOYSA-N 7,7,11,12-tetrafluoro-15-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound N1N=CC2=C1C(F)(F)C1C=3C=C(F)C(F)=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 ZIQJRGUIJUOBCN-UHFFFAOYSA-N 0.000 claims 1
- XVNAQZWJSJINLR-UHFFFAOYSA-N 7,7,11,12-tetrafluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaene Chemical compound N1N=CC2=C1C(F)(F)C1C=3C=C(F)C(F)=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 XVNAQZWJSJINLR-UHFFFAOYSA-N 0.000 claims 1
- WAFIKIXEWYWANV-UHFFFAOYSA-N 7,7,13-trifluoro-15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9(14),10,12-pentaene Chemical compound C1=NNC(C2(F)F)=C1C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 WAFIKIXEWYWANV-UHFFFAOYSA-N 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims 1
- CAGXPYAJPFEKDF-UHFFFAOYSA-N C12=CC(O)=CC=C2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 Chemical compound C12=CC(O)=CC=C2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 CAGXPYAJPFEKDF-UHFFFAOYSA-N 0.000 claims 1
- LHXPNPPXTYGLFO-UHFFFAOYSA-N C1=2C(F)=CC=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=N1 Chemical compound C1=2C(F)=CC=CC=2C2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=N1 LHXPNPPXTYGLFO-UHFFFAOYSA-N 0.000 claims 1
- GIKARRRTTYAGEA-UHFFFAOYSA-N C1=2C(F)=CC=CC=2CC2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound C1=2C(F)=CC=CC=2CC2CC=3NN=CC=3C1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 GIKARRRTTYAGEA-UHFFFAOYSA-N 0.000 claims 1
- PPHWWWXAWQOTKJ-UHFFFAOYSA-N C1=CC(C(=O)C)=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 Chemical compound C1=CC(C(=O)C)=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 PPHWWWXAWQOTKJ-UHFFFAOYSA-N 0.000 claims 1
- QIZOOHRRVHPDAD-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(OC(=O)O3)=C3C=C12 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(OC(=O)O3)=C3C=C12 QIZOOHRRVHPDAD-UHFFFAOYSA-N 0.000 claims 1
- GHESRBOHVXWZCE-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(OCO3)=C3C=C12 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC(OCO3)=C3C=C12 GHESRBOHVXWZCE-UHFFFAOYSA-N 0.000 claims 1
- GZHGNEVVXDOMHY-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=NC=C12 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C1=CC=NC=C12 GZHGNEVVXDOMHY-UHFFFAOYSA-N 0.000 claims 1
- LCKJGUKNVXOMSY-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C=C2 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1C=C2 LCKJGUKNVXOMSY-UHFFFAOYSA-N 0.000 claims 1
- DAJLKAHBVBBQHI-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1CC1=CC=CC=C12 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(C=NN3)=C3CC1CC1=CC=CC=C12 DAJLKAHBVBBQHI-UHFFFAOYSA-N 0.000 claims 1
- VGZDBKSHIGNGSR-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(F)(F)C(NN=C3)=C3C1C1=CC=CC=C12 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(F)(F)C(NN=C3)=C3C1C1=CC=CC=C12 VGZDBKSHIGNGSR-UHFFFAOYSA-N 0.000 claims 1
- MXTAXDQUAASAIJ-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C3=CC=CC=C3CC1C(C=NN1)=C1C2 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C3=CC=CC=C3CC1C(C=NN1)=C1C2 MXTAXDQUAASAIJ-UHFFFAOYSA-N 0.000 claims 1
- FTWFXCFPSLTKBO-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3C(CC3)=O)CC1CC1=C2C=NN1 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3C(CC3)=O)CC1CC1=C2C=NN1 FTWFXCFPSLTKBO-UHFFFAOYSA-N 0.000 claims 1
- ZPRUQFHRRGJCEQ-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3C(COCC3)=O)CC1CC1=C2C=NN1 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3C(COCC3)=O)CC1CC1=C2C=NN1 ZPRUQFHRRGJCEQ-UHFFFAOYSA-N 0.000 claims 1
- KSFWXCFAHNLMHZ-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3N=NSC=3)CC1CC1=C2C=NN1 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3N=NSC=3)CC1CC1=C2C=NN1 KSFWXCFAHNLMHZ-UHFFFAOYSA-N 0.000 claims 1
- VYLWGYPNPLKKRZ-UHFFFAOYSA-N C1=CC(Cl)=CC=C1S(=O)(=O)N1C2CC(C3=NNN=C3)CC1CC1=C2C=NN1 Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1C2CC(C3=NNN=C3)CC1CC1=C2C=NN1 VYLWGYPNPLKKRZ-UHFFFAOYSA-N 0.000 claims 1
- JSPOUIMZVUHFRV-UHFFFAOYSA-N C1=CC(F)=CC=C1C1=CC2C(C=NN3)=C3CC1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound C1=CC(F)=CC=C1C1=CC2C(C=NN3)=C3CC1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 JSPOUIMZVUHFRV-UHFFFAOYSA-N 0.000 claims 1
- OTEOJJMJLKQFOZ-UHFFFAOYSA-N C1=CC(F)=CC=C1C1=CC2N(S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C1C(C=NN1)=C1C2 Chemical compound C1=CC(F)=CC=C1C1=CC2N(S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C1C(C=NN1)=C1C2 OTEOJJMJLKQFOZ-UHFFFAOYSA-N 0.000 claims 1
- NUKOVQZRZUKNJP-UHFFFAOYSA-N C1=CC(F)=CC=C1C1=CC=CC2=C1C1C(C=NN3)=C3CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 Chemical compound C1=CC(F)=CC=C1C1=CC=CC2=C1C1C(C=NN3)=C3CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 NUKOVQZRZUKNJP-UHFFFAOYSA-N 0.000 claims 1
- PEBJJTXZDKDZAE-UHFFFAOYSA-N C1=CC(F)=CC=C1C1=CC=CC2=C1C1N(S(=O)(=O)C=3C=NC(=CC=3)C(F)(F)F)C2C(C=NN2)=C2C1 Chemical compound C1=CC(F)=CC=C1C1=CC=CC2=C1C1N(S(=O)(=O)C=3C=NC(=CC=3)C(F)(F)F)C2C(C=NN2)=C2C1 PEBJJTXZDKDZAE-UHFFFAOYSA-N 0.000 claims 1
- SAGGTTLMKGEAME-UHFFFAOYSA-N C1=CC(F)=CC=C1C1=CC=CC2=C1CC1C(C=NN3)=C3CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound C1=CC(F)=CC=C1C1=CC=CC2=C1CC1C(C=NN3)=C3CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 SAGGTTLMKGEAME-UHFFFAOYSA-N 0.000 claims 1
- MCKRBDAVTGLTSH-UHFFFAOYSA-N C1=CC(F)=CC=C1C1C(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 Chemical compound C1=CC(F)=CC=C1C1C(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 MCKRBDAVTGLTSH-UHFFFAOYSA-N 0.000 claims 1
- LSUKVCFBORQHPR-UHFFFAOYSA-N C1=CC(NC(=O)C)=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 Chemical compound C1=CC(NC(=O)C)=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 LSUKVCFBORQHPR-UHFFFAOYSA-N 0.000 claims 1
- LDVRGNRPBRDGFK-UHFFFAOYSA-N C1=CC(NCCOCC(=O)O)=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 Chemical compound C1=CC(NCCOCC(=O)O)=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 LDVRGNRPBRDGFK-UHFFFAOYSA-N 0.000 claims 1
- TZPGQZDUQXIBDJ-UHFFFAOYSA-N C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(=O)C(NN=C3)=C3C1C1=C2C(Cl)=CC=C1 Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C(=O)C(NN=C3)=C3C1C1=C2C(Cl)=CC=C1 TZPGQZDUQXIBDJ-UHFFFAOYSA-N 0.000 claims 1
- MWABIHDBHOSMTC-UHFFFAOYSA-N C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C3=CC=CC(C4CC4)=C3CC1C(C=NN1)=C1C2 Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C3=CC=CC(C4CC4)=C3CC1C(C=NN1)=C1C2 MWABIHDBHOSMTC-UHFFFAOYSA-N 0.000 claims 1
- VNQODWBHNAITRN-UHFFFAOYSA-N C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C3=CC=CC=C3CC1C(C=NN1)=C1C2 Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2C3=CC=CC=C3CC1C(C=NN1)=C1C2 VNQODWBHNAITRN-UHFFFAOYSA-N 0.000 claims 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 1
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 1
- IQTUWCVLGOJOGD-UHFFFAOYSA-N C=12C=CC=C(F)C=1C1C=3C=NNC=3C(F)C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound C=12C=CC=C(F)C=1C1C=3C=NNC=3C(F)C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 IQTUWCVLGOJOGD-UHFFFAOYSA-N 0.000 claims 1
- PSWJAPFUIAEDNM-UHFFFAOYSA-N CC1(C)CC2CC=3NN=CC=3N1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound CC1(C)CC2CC=3NN=CC=3N1N2S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 PSWJAPFUIAEDNM-UHFFFAOYSA-N 0.000 claims 1
- RAEZQPOUPDJJRK-UHFFFAOYSA-N CN1C=CC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C2)=N1 Chemical compound CN1C=CC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C2)=N1 RAEZQPOUPDJJRK-UHFFFAOYSA-N 0.000 claims 1
- VUSFHANERADPLI-UHFFFAOYSA-N CN1N=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 Chemical compound CN1N=CC=C1C1CC(N2S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 VUSFHANERADPLI-UHFFFAOYSA-N 0.000 claims 1
- POMIBIVUEIDWTM-UHFFFAOYSA-N CN1N=NC=C1C1CC(N2S(=O)(=O)C=3C=CC(Cl)=CC=3)C(C=NN3)=C3CC2C1 Chemical compound CN1N=NC=C1C1CC(N2S(=O)(=O)C=3C=CC(Cl)=CC=3)C(C=NN3)=C3CC2C1 POMIBIVUEIDWTM-UHFFFAOYSA-N 0.000 claims 1
- MQZFRMLGFYBKBW-UHFFFAOYSA-N COC(=O)c1cccc2C3N(C(Cc4[nH]ncc34)c12)S(=O)(=O)C1=CC=C(NC1)C(F)(F)F Chemical compound COC(=O)c1cccc2C3N(C(Cc4[nH]ncc34)c12)S(=O)(=O)C1=CC=C(NC1)C(F)(F)F MQZFRMLGFYBKBW-UHFFFAOYSA-N 0.000 claims 1
- XRHWIOQJWQQINO-UHFFFAOYSA-N N1C(C)=NC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C2)=N1 Chemical compound N1C(C)=NC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C2)=N1 XRHWIOQJWQQINO-UHFFFAOYSA-N 0.000 claims 1
- WKVNKWUBYBWWPP-UHFFFAOYSA-N N1N=CC2=C1C(=O)C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 Chemical compound N1N=CC2=C1C(=O)C1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 WKVNKWUBYBWWPP-UHFFFAOYSA-N 0.000 claims 1
- OUPPTQCQSOCETC-UHFFFAOYSA-N N1N=CC2=C1CC1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound N1N=CC2=C1CC1C=3C(F)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 OUPPTQCQSOCETC-UHFFFAOYSA-N 0.000 claims 1
- YOMTWQXKTDBHKD-UHFFFAOYSA-N N1N=CC2=C1CN1C(C)(C)CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 Chemical compound N1N=CC2=C1CN1C(C)(C)CC2N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 YOMTWQXKTDBHKD-UHFFFAOYSA-N 0.000 claims 1
- VAODCQDBZRVRAE-UHFFFAOYSA-N [15-[6-(trifluoromethyl)pyridin-3-yl]sulfonyl-4,5,15-triazatetracyclo[6.6.1.02,6.09,14]pentadeca-2(6),3,9,11,13-pentaen-10-yl]methanol Chemical compound N1N=CC2=C1CC1C=3C(CO)=CC=CC=3C2N1S(=O)(=O)C1=CC=C(C(F)(F)F)N=C1 VAODCQDBZRVRAE-UHFFFAOYSA-N 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- HOWZRGMUXMOUAI-UHFFFAOYSA-N chembl1837042 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC=CC=3)CC1CC1=C2C=NN1 HOWZRGMUXMOUAI-UHFFFAOYSA-N 0.000 claims 1
- DDQNBVZKZXCOQE-UHFFFAOYSA-N chembl1837043 Chemical compound C1=NC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC=CC=3)CC1CC1=C2C=NN1 DDQNBVZKZXCOQE-UHFFFAOYSA-N 0.000 claims 1
- WWBXWWWAZYGPBG-UHFFFAOYSA-N chembl1837044 Chemical compound S1C(Cl)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC=CC=3)CC1CC1=C2C=NN1 WWBXWWWAZYGPBG-UHFFFAOYSA-N 0.000 claims 1
- HIRONKBRYBENQL-UHFFFAOYSA-N chembl1837050 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3C(OCC3)=O)CC1CC1=C2C=NN1 HIRONKBRYBENQL-UHFFFAOYSA-N 0.000 claims 1
- RDNMKSJCMCSZGD-UHFFFAOYSA-N chembl1837051 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=CC(=CC=3)N3C=NC=C3)CC1CC1=C2C=NN1 RDNMKSJCMCSZGD-UHFFFAOYSA-N 0.000 claims 1
- JPQZUJGQGYTZPT-UHFFFAOYSA-N chembl1837054 Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1C2CC(C=3NC4=CC=CC=C4N=3)CC1CC1=C2C=NN1 JPQZUJGQGYTZPT-UHFFFAOYSA-N 0.000 claims 1
- KDNVMLRNFBKRHP-UHFFFAOYSA-N chembl1837055 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C=3C=NC=CC=3)CC1CC1=C2C=NN1 KDNVMLRNFBKRHP-UHFFFAOYSA-N 0.000 claims 1
- LEBFIEKFLKFSDA-UHFFFAOYSA-N chembl1837056 Chemical compound O1C(C)=CN=C1C1CC(N2S(=O)(=O)C=3C=NC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 LEBFIEKFLKFSDA-UHFFFAOYSA-N 0.000 claims 1
- LFEROJSQMPEGCL-UHFFFAOYSA-N chembl1837057 Chemical compound S1C(C)=CN=C1C1CC(N2S(=O)(=O)C=3C=NC(=CC=3)C(F)(F)F)C(C=NN3)=C3CC2C1 LFEROJSQMPEGCL-UHFFFAOYSA-N 0.000 claims 1
- CUGHGQZFDYOJGX-UHFFFAOYSA-N chembl1837058 Chemical compound S1C(C)=NN=C1C1CC(N2S(=O)(=O)C=3C=CC(Cl)=CC=3)C(C=NN3)=C3CC2C1 CUGHGQZFDYOJGX-UHFFFAOYSA-N 0.000 claims 1
- ROCXIAVBNAMBLQ-UHFFFAOYSA-N chembl1837059 Chemical compound CC1=NOC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=CC(Cl)=CC=3)C2)=N1 ROCXIAVBNAMBLQ-UHFFFAOYSA-N 0.000 claims 1
- SZVWQZIZRCBQFN-UHFFFAOYSA-N chembl1837060 Chemical compound FC(F)(F)C1=CSC(C2CC3C=4C=NNC=4CC(N3S(=O)(=O)C=3C=NC(=CC=3)C(F)(F)F)C2)=N1 SZVWQZIZRCBQFN-UHFFFAOYSA-N 0.000 claims 1
- GFLCDRXRUKOTNK-UHFFFAOYSA-N chembl1837062 Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C2CC(C3=NNC=N3)CC1CC1=C2C=NN1 GFLCDRXRUKOTNK-UHFFFAOYSA-N 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
- 0 CC(C(C)(c1c(C23*)c(*)ccc1C)N2S(C1=CC=CC=CC=CC=C1)(=O)=O)c1c3cn[n]1 Chemical compound CC(C(C)(c1c(C23*)c(*)ccc1C)N2S(C1=CC=CC=CC=CC=C1)(=O)=O)c1c3cn[n]1 0.000 description 2
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9479908P | 2008-09-05 | 2008-09-05 | |
| US61/094,799 | 2008-09-05 | ||
| US9924108P | 2008-09-23 | 2008-09-23 | |
| US61/099,241 | 2008-09-23 | ||
| US17327809P | 2009-04-28 | 2009-04-28 | |
| US61/173,278 | 2009-04-28 | ||
| US22653209P | 2009-07-17 | 2009-07-17 | |
| US61/226,532 | 2009-07-17 | ||
| PCT/US2009/055987 WO2010028213A2 (en) | 2008-09-05 | 2009-09-04 | N-sulfonamido polycyclic pyrazolyl compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012502051A JP2012502051A (ja) | 2012-01-26 |
| JP2012502051A5 true JP2012502051A5 (cg-RX-API-DMAC7.html) | 2012-10-25 |
Family
ID=41258775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526217A Pending JP2012502051A (ja) | 2008-09-05 | 2009-09-04 | N−スルホンアミドポリシクル酸ピラゾリル化合物 |
Country Status (20)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009289649B2 (en) | 2008-09-03 | 2016-05-05 | Biomarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors |
| US8283358B2 (en) | 2008-09-05 | 2012-10-09 | Elan Pharmaceuticals, Inc. | N-sulfonamido polycyclic pyrazolyl compounds |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| WO2012118782A1 (en) | 2011-02-28 | 2012-09-07 | Repligen Corporation | Histone deacetylase inhibitors |
| RU2665554C2 (ru) | 2013-03-15 | 2018-08-31 | Байомарин Фармасьютикал Инк. | Ингибиторы hdac |
| EP4084797A4 (en) * | 2020-01-03 | 2024-02-21 | Blue Oak Pharmaceuticals, Inc. | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISEASES |
| CN111909217B (zh) * | 2020-08-20 | 2023-05-02 | 昆明贵金属研究所 | 一种双(二叔丁基-4-二甲氨基苯基膦)四溴双钯(ⅱ)化合物及其制备方法和用途 |
| CN115448892B (zh) * | 2022-09-19 | 2023-07-07 | 郑州铁路职业技术学院 | 一种苯并噻二唑杂环化合物的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8727989D0 (en) * | 1987-11-30 | 1988-01-06 | Merck Sharp & Dohme | Therapeutic agents |
| EP0330788A1 (en) | 1988-03-01 | 1989-09-06 | Merrell Dow Pharmaceuticals Inc. | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia |
| WO2005113542A2 (en) | 2004-05-20 | 2005-12-01 | Elan Pharmaceuticals, Inc. | N-cyclic sulfonamido inhibitors of gamma secretase |
| JP2009504773A (ja) * | 2005-08-19 | 2009-02-05 | エラン ファーマシューティカルズ,インコーポレイテッド | ガンマセクレターゼの架橋n−二環式スルホンアミド阻害剤 |
| TW200813054A (en) | 2006-06-02 | 2008-03-16 | Elan Pharm Inc | Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| CN101128035B (zh) | 2006-08-18 | 2011-08-24 | 中兴通讯股份有限公司 | 时分码分多址系统中信道间的定时方法 |
| MX2009012525A (es) * | 2007-05-25 | 2009-12-09 | Elan Pharm Inc | Pirazol-pirrolidinas como inhibidores de gamma secretasa. |
| US8283358B2 (en) | 2008-09-05 | 2012-10-09 | Elan Pharmaceuticals, Inc. | N-sulfonamido polycyclic pyrazolyl compounds |
-
2009
- 2009-09-04 US US12/554,134 patent/US8283358B2/en not_active Expired - Fee Related
- 2009-09-04 EA EA201170421A patent/EA201170421A1/ru unknown
- 2009-09-04 TW TW098129931A patent/TW201014856A/zh unknown
- 2009-09-04 AR ARP090103413A patent/AR073497A1/es not_active Application Discontinuation
- 2009-09-04 AU AU2009289579A patent/AU2009289579A1/en not_active Abandoned
- 2009-09-04 CN CN2009801426386A patent/CN102203089A/zh active Pending
- 2009-09-04 BR BRPI0918213A patent/BRPI0918213A2/pt not_active IP Right Cessation
- 2009-09-04 WO PCT/US2009/055987 patent/WO2010028213A2/en not_active Ceased
- 2009-09-04 EP EP09792258A patent/EP2346863A2/en not_active Withdrawn
- 2009-09-04 PE PE2011000438A patent/PE20110418A1/es not_active Application Discontinuation
- 2009-09-04 CA CA2736767A patent/CA2736767A1/en not_active Abandoned
- 2009-09-04 MX MX2011002047A patent/MX2011002047A/es unknown
- 2009-09-04 JP JP2011526217A patent/JP2012502051A/ja active Pending
- 2009-09-04 KR KR1020117007863A patent/KR20110055715A/ko not_active Withdrawn
-
2011
- 2011-02-17 IL IL211263A patent/IL211263A0/en unknown
- 2011-02-24 CL CL2011000405A patent/CL2011000405A1/es unknown
- 2011-03-16 ZA ZA2011/01994A patent/ZA201101994B/en unknown
- 2011-03-31 CO CO11039494A patent/CO6362008A2/es not_active Application Discontinuation
- 2011-04-01 MA MA33737A patent/MA32688B1/fr unknown
- 2011-04-01 EC EC2011010947A patent/ECSP11010947A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102926301B1 (ko) | Shp2 포스파타제 억제제 및 그의 사용 방법 | |
| KR101676886B1 (ko) | 박테리아 감염의 치료를 위한 융합된 스피로시클릭 헤테로방향족 화합물 | |
| CA2762174C (en) | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors | |
| KR101449217B1 (ko) | 벤즈옥세핀 pi3k 억제제 화합물 및 사용 방법 | |
| KR101659193B1 (ko) | Btk 활성의 억제제로서의 헤테로아릴 피리돈 및 아자-피리돈 화합물 | |
| JP2020514267A5 (cg-RX-API-DMAC7.html) | ||
| AU2010332955B2 (en) | 3,4,4a,10b-tetrahydro-1H-thiopyrano-[4, 3-c] isoquinoline derivatives | |
| JP2021503004A5 (cg-RX-API-DMAC7.html) | ||
| WO2018218133A1 (en) | Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors | |
| KR20120065431A (ko) | 벤즈옥사제핀 pi3k 억제 화합물 및 사용 방법 | |
| AU2013305390A1 (en) | Dihydropyrimidine compounds and their application in pharmaceuticals | |
| CA2827161A1 (en) | 6,5-heterocyclic propargylic alcohol compounds and uses therefor | |
| WO2023212240A1 (en) | Compounds for inhibiting kif18a | |
| KR20150002573A (ko) | 벤조티아졸-6-일 아세트산 유도체 및 hiv 감염을 치료하기 위한 이의 용도 | |
| AU2020241254A1 (en) | Macrocyclic azolopyridine derivatives as EED and PRC2 modulators | |
| JP2016507551A5 (cg-RX-API-DMAC7.html) | ||
| JP2021501806A5 (cg-RX-API-DMAC7.html) | ||
| RU2017118562A (ru) | Соединения-антагонисты дофаминового d3-рецептора | |
| CA3187915A1 (en) | Atr inhibitors and uses thereof | |
| WO2012085857A1 (en) | 3,8-diaza-bicyclo[4.2.0]oct-3-yl amides | |
| JP2013518823A5 (cg-RX-API-DMAC7.html) | ||
| JP2023551290A (ja) | ピロリジン誘導体及び使用方法 | |
| JP2024511832A (ja) | Stingアゴニストとして有用な新規化合物およびその使用 | |
| WO2013120980A1 (en) | Tricyclic compounds and methods of use therefor | |
| AU2024253757A1 (en) | 1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (tyk2) inhibitors for the treatment of inflammatory diseases |